Gonadotropin-releasing hormone analogues for endometriosis-Reference-Cited by-同舟云学术

Gonadotropin-releasing hormone analogues for endometriosis

Published:2023-06-21 Issue:6 Volume:2023 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Veth Veerle B¹,van de Kar Majorie MA²,Duffy James MN³,van Wely Madelon⁴,Mijatovic Velja⁵,Maas Jacques WM⁶

Affiliation:

1. Department of Obstetrics & Gynecology; Maastricht University Medical Center (MUMC+); Maastricht Netherlands

2. Emergency Department; Laurentius Ziekenhuis; Roermond Netherlands

3. King's Fertility; The Fetal Medicine Research Institute; London UK

4. Center for Reproductive Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

5. Academic Endometriosis Center, Department of Reproductive Medicine; Amsterdam UMC; Amsterdam Netherlands

6. Department of Obstetrics & Gynaecology; Maastricht University Medical Center (MUMC+); Maastricht Netherlands

Publisher

Wiley

Subject

Pharmacology (medical)

Reference199 articles.

1. Dienogest versus leuprolide acetate for recurrent pelvic pain following laparoscopic treatment of endometriosis;Abdou;Journal of Obstetrics and Gynecology of India

2. Pain of endometriosis: effects of nafarelin and danazol therapy;Adamson;International Journal of Fertility & Menopausal Studies,1994

3. Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group;Agarwal;Journal of Reproductive Medicine,1997

4. Goserelin depot versus danazol in the treatment of endometriosis the Australian/New Zealand experience;Australian & New Zealand Journal of Obstetrics & Gynaecology,1996

5. Efficacy and safety of slow-release leuprorelin 3,75 mg compared to danazol treatment. ;Audebert;References en Gynecologie Obstetrique,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying novel potential drug targets for endometriosis via plasma proteome screening;Frontiers in Endocrinology;2024-07-05

2. A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases;Frontiers in Pharmacology;2024-07-04

3. Abnormal HCK/glutamine/autophagy axis promotes endometriosis development by impairing macrophage phagocytosis;Cell Proliferation;2024-07-02

4. Review of bone health in women receiving endocrine therapy because of breast cancer;ORVOSI HETILAP;2024

5. Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery;BMC Pregnancy and Childbirth;2024-04-04